Camp4 Therapeutics Corporation (CAMP)

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023
Biotechnology (Startups)	3.50M	652.00K	350.00K
Biotechnology (Startups) Growth	436.50%	86.29%	-
Total	3.50M	652.00K	350.00K
Total Growth	436.50%	86.29%	-

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023
United States	3.50M	652.00K	350.00K
United States Growth	436.50%	86.29%	-
Total	3.50M	652.00K	350.00K
Total Growth	436.50%	86.29%	-

Source: S&P Global Market Intelligence.